Carmell Co. (NASDAQ:CTCX) Short Interest Up 18.3% in May

Carmell Co. (NASDAQ:CTCX) was the target of a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 35,500 shares, an increase of 18.3% from the May 15th total of 30,000 shares. Currently, 0.3% of the company’s shares are sold short. Based on an average trading volume of 10,700 shares, the days-to-cover ratio is presently 3.3 days.

Carmell Stock Down 8.0 %

Shares of Carmell stock opened at $1.83 on Tuesday. Carmell has a one year low of $1.70 and a one year high of $13.31. The business’s 50 day simple moving average is $2.29 and its two-hundred day simple moving average is $2.91.

Carmell (NASDAQ:CTCX) last issued its earnings results on Wednesday, May 15th. The company reported ($0.16) EPS for the quarter.

Hedge Funds Weigh In On Carmell

Several hedge funds and other institutional investors have recently modified their holdings of CTCX. Meteora Capital LLC bought a new position in shares of Carmell during the third quarter valued at approximately $6,416,000. Linden Advisors LP bought a new stake in Carmell in the third quarter valued at $270,000. Finally, Hubbell Strickland Wealth Management LLC purchased a new position in Carmell during the 1st quarter valued at $32,000. 24.22% of the stock is owned by institutional investors.

About Carmell

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.